pharma · Tuberculosis · Meningococcal Meningitis
CanSino Biologics
CanSino Biologics patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Tianjin, CN HQ
2009 Founded
138 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Tianjin, CN
- Founded
- 2009
- Employees
- 138
- Programs
- 3
- Drugs
- 9
- Patents
- 0
CanSino Biologics patents
0 pharmaceutical patents indexed for CanSino Biologics. 0 expire within 24 months.
CanSino Biologics has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does CanSino Biologics have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do CanSino Biologics patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.